Nexpoint Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-82,000
Closed -$1.6M 250
2021
Q3
$1.6M Buy
82,000
+52,000
+173% +$1.98M 0.28% 47
2021
Q2
$1.34M Buy
+30,000
New +$1.39M 0.29% 48

Other funds holding CELL

Nexpoint Asset Management's CELL Position: Q4 2021 in Review

Nexpoint Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 82,000 shares — an estimated $1.6M sold.

Nexpoint Asset Management first reported a position in CELL in Q2 2021 and held it in 2 quarters. The position peaked at $1.6M in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Nexpoint Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Nexpoint Asset Management sold 82,000 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $1.6M.
  • Nexpoint Asset Management first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Nexpoint Asset Management's PhenomeX Inc. Common Stock position peaked at $1.6M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Nexpoint Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.